Sidera Bio

Harnessing human genetics to deliver transformative medicines for patients.

Cambridge, United States · $109.0M raised

Business Model
B2B
Total Funding
$109.0M
Last Round
$109.0M Series ADec 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Sidera Bio focuses on transformative cardiometabolic therapies. Its stated approach is to harness human genetics to deliver transformative medicines for patients. The official site lists locations in Copenhagen, Denmark, and Cambridge, Massachusetts. It currently labels the fuller company profile as coming soon, so first-party detail about specific therapeutic programs, development stages, and patient populations remains limited.

Summary

Sidera Bio is a Biotech company based in Cambridge, United States. It has raised $109.0M in total across 1 round, most recently a $109.0M Series A round in Dec 2025. Investors include Novo Holdings A/S, Forbion Capital Partners and RA Capital Management.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ADec 2025
$109.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sidera Bio on Indexed.vc
<a href="https://indexed.vc/companies/sidera-bio"><img src="https://indexed.vc/api/badge/company/sidera-bio" alt="Sidera Bio on Indexed.vc" width="260" height="76" /></a>